Atherosclerosis in LDLR-Knockout Mice Is Inhibited, but Not Reversed, by the PPARγ Ligand Pioglitazone - Concepedia

Concepedia

Publication | Open Access

Atherosclerosis in LDLR-Knockout Mice Is Inhibited, but Not Reversed, by the PPARγ Ligand Pioglitazone

DOI Full Paper Access

28

Citations

51

References

2009

Year

Hideaki Nakaya, Barbara D. Summers, Andrew Nicholson, Antonio M. Gotto, David P. Hajjar, Jihong Han

American Journal Of Pathology

InflammationMetabolic SyndromeVascular DiseaseMolecular PhysiologyMedicinePhysiologyHyperlipidemiaVascular BiologyLipoprotein MetabolismPparγ Ligand PioglitazonePharmacologyCardiovascular Disease PathogenesisAtherosclerosisDyslipidemiaHealth Sciences

References

	Year	Citations

Page 1

Page 1